LBA55 Mechanisms of Acquired Resistance to First-Line Amivantamab Plus Lazertinib Versus Osimertinib in Patients with EGFR-mutant Advanced Non-Small Cell Lung Cancer: an Early Analysis from the Phase III MARIPOSA Study
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined